Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000–2013
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Invasive aspergillosis (IA) and mucormycosis contribute to substantial mortality, especially among immunocompromised persons, including those with hematopoietic stem cell transplant (HSCT), hematologic malignancy (HM), and solid organ transplant (SOT). Methods: Using International Classification of Diseases, Ninth Revision codes available in the National Inpatient Sample, a hospital discharge database, we estimated IA-related hospitalizations (IA-RH), mucormycosis-RH (M-RH), HSCT-RH, HM-RH, and SOT-RH during 2000–2013. United States census data were used to calculate overall M-RH and IA-RH rates and present trends; estimated annual numbers of HSCT-RH, HM-RH, and SOT-RH served as denominators to calculate M-RH and IA-RH rates occurring with these conditions. Weighted least-squares technique was used to test for linear trends and calculate average annual percentage change (APC). Results: There were an estimated 169 110 IA-RH and 9966 M-RH during 2000–2013. Overall, IA-RH and M-RH rates per million persons rose from 32.8 to 46.0 (APC = +2.9; P < .001) and 1.7 to 3.4 (APC = +5.2%; P < .001), respectively, from 2000 to 2013. Among HSCT-RH, there was no significant change in M-RH rate, but a significant decline occurred in IA-RH rate (APC = −4.6%; P = .004). Among HM-RH, the rate of M-RH increased (APC = +7.0%; P < .001), but the IA-RH rate did not change significantly (APC = +1.2%; P = .073). Among SOT-RH, M-RH (APC = +6.3%; P = .038) and IA-RH rates (APC = +4.1%; P < .001) both increased. Conclusions: Overall IA-RH and M-RH rates increased during 2000–2013, with a doubling of M-RH. Mucormycosis-related hospitalization occurring in conjunction with certain comorbidities increased, whereas IA-RH rates among patients with the comorbidities, decreased, remained stable, or increased to a lesser extent than M-RH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Healthcare Cost and Utilization Project (HCUP)
(2016) · The SAGE Encyclopedia of Pharmacology and Society · doi:10.4135/9781483349985.n182 · Cited by 1,035
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Skiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495 · cited 2×
“Improved diagnostics, especially with introduction of the galactomannan assay in the last decade, may have altered detection of IA and hence observed trends in IA [13].”
BackgroundResultWingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268151 · Cited by 482
Maertens, J., Marchetti, O., Herbrecht, R., Cornely, O. A., Flückiger, U., Frêre, P., Gachot, B., Heinz, W. J., Lass-Flörl, C., Ribaud, P., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.175 · Cited by 470
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426
Rees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397 · cited 1×
“7 cases per 1 million persons for mucormycosis [7].”
BackgroundWalsh, T. J., Gamaletsou, M. N., McGinnis, M. R., Hayden, R. T., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir868 · Cited by 386
Minari, A., Husni, R., Avery, R. K., Longworth, D. L., DeCamp, M., Bertin, M., Schilz, R., Smedira, N., Haug, M. T., Mehta, A., et al. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.t01-2-02002.x · Cited by 351
Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., et al. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110087 · Cited by 321
Geographic Distribution of Diagnosed Diabetes in the U.S.
Barker, L. E., Kirtland, K. A., Gregg, E. W., Geiss, L. S., & Thompson, T. J. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.12.019 · Cited by 319
Siwek, G. T., Dodgson, K. J., de Margarida, M.-S., Bartelt, L. A., Kilborn, S. B., Hoth, P. L., Diekema, D. J., & Pfaller, M. A. (2004) · Clinical Infectious Diseases · doi:10.1086/422723 · Cited by 293
Lewis, R. E., Cahyame‐Zuniga, L., Leventakos, K., Chamilos, G., Ben‐Ami, R., Tamboli, P., Tarrand, J., Bodey, G. P., Luna, M., & Kontoyiannis, D. P. (2013) · Mycoses · doi:10.1111/myc.12081 · Cited by 248
Zaoutis, T. E., Heydon, K., Chu, J. H., Walsh, T. J., & Steinbach, W. J. (2006) · Pediatrics · doi:10.1542/peds.2005-1161 · Cited by 241
Singh, N., Aguado, J. M., Bonatti, H., Forrest, G., Gupta, K. L., Safdar, N., John, G. T., Pursell, K. J., Muñoz, P., Patel, R., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605445 · Cited by 233
Trifilio, S. M., Bennett, C. L., Yarnold, P. R., McKoy, J. M., Parada, J., Mehta, J., Chamilos, G., Palella, F., Kennedy, L., Mullane, K., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705614 · Cited by 230
Voriconazole Prophylaxis in Lung Transplant Recipients
Husain, S., Paterson, D. L., Studer, S., Pilewski, J., Crespo, M., Zaldonis, D., Shutt, K., Pakstis, D. L., Zeevi, A., Johnson, B., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01548.x · Cited by 215
Mucormycosis in Organ and Stem Cell Transplant Recipients
Lanternier, F., Sun, H.-Y., Ribaud, P., Singh, N., Kontoyiannis, D. P., & Lortholary, O. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis195 · Cited by 212
Antifungal Prophylaxis in Lung Transplantation—A World-wide Survey
Neoh, C. F., Snell, G. I., Kotsimbos, T., Levvey, B., Morrissey, C. O., Slavin, M. A., Stewart, K., & Kong, D. C. M. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03375.x · Cited by 147
Neofytos, D., Treadway, S., Ostrander, D., Alonso, C. D., Dierberg, K. L., Nussenblatt, V., Durand, C. M., Thompson, C. B., & Marr, K. A. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12060 · Cited by 135
Kontoyiannis, D. P., Yang, H., Song, J., Kelkar, S. S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., & Spalding, J. R. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2023-z · Cited by 132 · cited 1×
“It is interesting to note that a recent analysis of a proprietary database containing discharge diagnoses at 560 participating US hospitals during 2005–2014 did not reveal an increasing trend in M-RHs [22]; the selection of hospitals included in this database may account for the difference in observed trends of mucorm…”
ResultIncreasing Incidence of Mucormycosis in University Hospital, Belgium
Saegeman, V., Maertens, J. A., Meersseman, W., Spriet, I., Verbeken, E. V., & Lagrou, K. (2010) · Emerging infectious diseases · doi:10.3201/eid1609.100276 · Cited by 119
Epidemiology of mucormycosis in Europe
Petrikkos, G. L., Skiada, A., & Drogari‐Apiranthitou, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12563 · Cited by 91
Immunological Basis for the Gender Differences in Murine Paracoccidioides brasiliensis Infection
Pinzan, C. F., Ruas, L. P., Casabona-Fortunato, A. S., Carvalho, F. C., & Roque-Barreira, M.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010757 · Cited by 83
Trends in hospital utilization: united states, 1988-92.
Gillum, B. S., Graves, E. J., & Jean, L. (1996) · PubMed · Cited by 82
Zilberberg, M. D., Shorr, A. F., Huang, H., Chaudhari, P., Paly, V. F., & Menzin, J. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-310 · Cited by 62
Sinkó, J., Csomor, J., Nikolova, R., Lueff, S., Kriván, G., Reményi, P., Bátai, Á., & Masszi, T. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00264.x · Cited by 57
Novosad, S., Vasquez, A. M., Nambiar, A., Arduino, M. J., Christensen, E., Moulton-Meissner, H. A., Keckler, M. S., Miller, J., Perz, J. F., Lockhart, S. R., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6518a5 · Cited by 23
Self-citationMucormycosis: a new concern in the transplant ward?
Robin, C., Alanio, A., & Cordonnier, C. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000082 · Cited by 19
Research works printed but not linked: 1
- Park, 2011, Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006, Emerg Infect Dis, 17, 1855, 10.3201/eid1710.110087 · DOI · Paper page
Cited by
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
“This finding is particularly notable since mucormycosis rates doubled from 2000 to 2013 [23].”
BackgroundSelf-citationThe rapid emergence of antifungal-resistant human-pathogenic fungi
Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 308
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?
Kidd, S. E., Chen, S. C.-A., Meyer, W., & Halliday, C. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02903 · Cited by 166
Burden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Self-citationToda, M., Beer, K. D., Kuivila, K. M., Chiller, T. M., & Jackson, B. R. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7484 · Cited by 161
Metadata
- Authors
- Vallabhaneni, S., Benedict, K., Derado, G., & Mody, R. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-01
- Volume
- 4
- Issue
- 1
- Pages
- ofw268-ofw268
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC5413990
- OpenAlex
- W2577939788
- Cited by
- 98
- References
- 37
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 7 · 2023: 13 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 14 · 2018: 8 · 2017: 1
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Open Forum Infectious Diseases (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- invasive aspergillosis, mucormycosis, hospitalization trends, hematopoietic stem cell transplantation, hematologic malignancies, solid organ transplantation, immunocompromised patients, fungal infection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.